Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy
US9522123B2 · kind B2 · utility
59Cited by
6References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 22, 2014 |
| Grant date | Dec 20, 2016 |
| Priority date | — |
| Expiry date | Dec 22, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to the use of one or more cannabinoids in the treatment of epilepsy and more particularly to the use of one or a combination of cannabinoids in the treatment of generalized or partial seizure. In one embodiment it relates to the use of the cannabinoid THCV, as a pure or isolated compound, or as a plant extract in which significant amounts of any THC naturally present has been selectively removed. In another embodiment the phytocannabinoid is CBD.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.